(Q37776318)

23 August 2017

1 reference

title

A comparison of methods of pathogen inactivation of FFP (English)

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

12 June 2024

author name string

G. Rock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20667071

12 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20667071

12 June 2024

publication date

1 February 2011

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1423-0410.2010.01374.x

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1423-0410.2010.01374.x

12 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

12 June 2024

1 reference

23 August 2017

volume

100

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

169-178

1 reference

Current status of solvent/detergent-treated frozen plasma

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Outbreak of hepatitis A among Italian patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Inactivation of viruses in fresh-frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Solvent/detergent-treated plasma: composition, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Properties of pathogen-inactivated plasma components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Solvent-detergent-treated fresh frozen plasma: a superior alternative to standard fresh frozen plasma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The influence of riboflavin photochemistry on plasma coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

A comparison of complication rates based on published haemovigilance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Photodynamic virus inactivation of blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Updates on pathogen inactivation of plasma using Theraflex methylene blue system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

West Nile virus in plasma is highly sensitive to methylene blue-light treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Viral inactivation of fresh frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Update on pathogen reduction technology for therapeutic plasma: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Emerging infectious disease agents and their potential threat to transfusion safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Pathogen reduction: a precautionary principle paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2010.01374.X

The effect of virus inactivation on coagulation factors in therapeutic plasma

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

Pathogen inactivated transfusion plasma: existing and emerging methods.

12 June 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma

12 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?

12 June 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen

12 June 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma

12 June 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.2010.01374.X

12 June 2024

Identifiers

1 reference

23 August 2017

1 reference